Owner experiences in treating dogs and cats diagnosed with diabetes mellitus in the United States

J Am Anim Hosp Assoc. 2014 Jul-Aug;50(4):247-53. doi: 10.5326/JAAHA-MS-6101.

Abstract

The objective of this study was to report owner experiences and satisfaction in treating a pet with diabetes mellitus using a descriptive report from an Internet-based survey. Descriptive analysis of results was performed, χ(2) tests were used to detect differences in responses between dog and cat owners, and correlations were assessed using the nonparametric Spearman rank correlation. A total of 834 owners participated in the survey. More diabetic dogs (97%) than cats (82%) were treated with insulin injections. Insulin was administered twice daily in 87% of dogs and 73% of cats. Porcine lente and neutral protamine Hagedorn were the most commonly administered insulins in dogs. In cats, glargine and protamine zinc insulin were the most commonly used insulins. Most pets were not fed a prescribed diabetes diet. More cat (66%) than dog (50%) owners were satisfied with the diabetic control achieved. Cat owners were more likely to use home blood glucose monitoring. Treatment was considered expensive by the majority of owners. Few published reports follow diabetic pets after diagnosis or report owner satisfaction. The results of this study provide useful information that may help veterinarians better educate owners and set expectations regarding diabetes treatment and quality of life for diabetic pets.

MeSH terms

  • Animals
  • Cat Diseases / psychology
  • Cat Diseases / therapy*
  • Cats
  • Diabetes Mellitus / psychology
  • Diabetes Mellitus / therapy
  • Diabetes Mellitus / veterinary*
  • Dog Diseases / psychology
  • Dog Diseases / therapy*
  • Dogs
  • Humans
  • Hypoglycemic Agents / administration & dosage
  • Injections / psychology
  • Injections / veterinary
  • Insulin / administration & dosage
  • Ownership*
  • Patient Satisfaction*
  • Quality of Life
  • Surveys and Questionnaires
  • United States

Substances

  • Hypoglycemic Agents
  • Insulin